Xu et al.'s study also highlighted that the CD3 immune cell phenotype on CD28+CD4-CD8-T cells and the HLA-DR expression on CD33-HLA-DR+ cells exhibit protective effects against breast cancer 79. Here, CD33 is linked to breast cancer.